Skip to main content
. 2015 Sep 15;10(9):e0137375. doi: 10.1371/journal.pone.0137375

Table 3. Associations of demographic and serological markers with risk of infection with HBV or HCV.

Risk Factor Hepatitis B surface antigen, N (%) Hepatitis C antibodies, N (%)
HBsAg+ HBsAg- OR(95%CI) Ptrend Present Absent OR(95%CI) Ptrend
Age Group 0381 0.582
  14–30 33(36.2) 92(22.7) Reference 6(15.8) 119(24.1) Reference
  31–40 38(30.2) 114(28.1) 0.69(0.25–1.9) 12(31.6) 140(28.4) 1.56(0.25–9.8)
  41–50 26(20.6) 81(20.0) 0.62(0.22–1.8) 8(21.0) 99(20.1) 0.67(0.08–5.3)
    >50 7(5.6) 59(14.6) 0.43(0.10–1.8) 8(21.0) 58(11.7) 1.70(0.19–14.5)
Sex 0.658 0.509
  Female 79(62.7) 240(59.3) Reference 21(55.3) 298(60.4) Reference
  Male 32(25.4) 118(29.1) 2.39(1.01–5.6) 13(34.2) 137(21.8) 0.40(0.05–1.8)
CD4 Count 0.425 0.481
  <250 16(20.3) 49(24.7) Reference 3(16.7) 62(23.9) Reference
  > = 250 63(79.7) 149(75.3) 0.37(0.15–0.9) 15(83.3) 197(76.1) 0.47 (0.10–2.4)
Residence 0.01 0.106
  Rural 14(11.1) 87(21.5) Reference 11(28.9) 90(18.3) Reference
  Urban 112(88.9) 318(78.5) 2.19(1.9–4.0) 27(71.1) 403(81.7) 0.58(0.26–1.1)
Regions 0.0001 0.013
  Western 40(31.7) 231(57.0) Reference 12(31.6) 259(52.5) Reference
  Eastern 86(68.3) 174(43.0) 3.20 (1.6–6.3) 26(68.4) 234(47.5) 2.16(0.70–6.7)
Sexual Partners 0.397
  One 41(72.9) 141(81.5) Reference 14(87.5) 168(78.5) Reference
  Multiple 16(28.1) 32(18.5) 1.28(0.60–2.7) 2(12.5) 46(21.5) 0.40(0.08–1.9)

Percentages (%) in columns were calculated by dividing the number of participants with a particular outcome by the total number of participants with the outcome of interest *100. Adjustments were made for age, sex, CD4 count, residence, region and number of sexual partners.

HBV, Hepatitis B virus; HCV, Hepatitis C virus